1. Home
  2. DUO vs AYTU Comparison

DUO vs AYTU Comparison

Compare DUO & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DUO

Fangdd Network Group Ltd.

HOLD

Current Price

$0.58

Market Cap

24.6M

Sector

Finance

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$1.99

Market Cap

27.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DUO
AYTU
Founded
2011
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.6M
27.4M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
DUO
AYTU
Price
$0.58
$1.99
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $9.67
AVG Volume (30 Days)
★ 107.2K
42.9K
Earning Date
08-28-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $27,632,080.00
Revenue This Year
N/A
$17.96
Revenue Next Year
N/A
$27.98
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 277.47
52 Week Low
$0.42
$1.80
52 Week High
$2.90
$3.07

Technical Indicators

Market Signals
Indicator
DUO
AYTU
Relative Strength Index (RSI) 46.38 46.09
Support Level $0.57 $1.89
Resistance Level $0.70 $2.34
Average True Range (ATR) 0.06 0.08
MACD -0.00 -0.00
Stochastic Oscillator 17.91 43.07

Price Performance

Historical Comparison
DUO
AYTU

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China. All revenues of the Group are derived from the PRC.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: